These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 8538585

  • 1. [Oral administration of OK-432 is an effective immunotherapy against colon cancer--a study in a murine mesenteric lymphnode metastasis model].
    Nukata Y, Shiiba K, Ebine N, Ishii S, Matsuno S.
    Nihon Geka Gakkai Zasshi; 1995 Oct; 96(10):671-9. PubMed ID: 8538585
    [Abstract] [Full Text] [Related]

  • 2. [Inhibitory effects of OK-432 administered orally on colon carcinoma induced by DMH in rats].
    Yasuda N, Shibusawa M, Tsunoda A, Nakao K, Yoshizawa F, Komatsu N, Kusano M.
    Nihon Geka Gakkai Zasshi; 1994 Sep; 95(9):655-61. PubMed ID: 7838106
    [Abstract] [Full Text] [Related]

  • 3. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA, Flye MW.
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y, Shiraishi T, Tsuchitani T, Tobe T, Sugawara Y, Saito M, Kamiyama H.
    In Vivo; 1989 Aug; 3(5):307-13. PubMed ID: 2519870
    [Abstract] [Full Text] [Related]

  • 5. Application of an interleukin 2 slow delivery system to the immunotherapy of established murine colon 26 adenocarcinoma liver metastases.
    Fujiwara T, Sakagami K, Matsuoka J, Shiozaki S, Uchida S, Fujioka K, Takada Y, Onoda T, Orita K.
    Cancer Res; 1990 Nov 01; 50(21):7003-7. PubMed ID: 2208166
    [Abstract] [Full Text] [Related]

  • 6. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
    Inoh A, Kodama Y, Yokoro K.
    Hiroshima J Med Sci; 1989 Dec 01; 38(4):213-9. PubMed ID: 2637250
    [Abstract] [Full Text] [Related]

  • 7. Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intact tumor tissue in nude mice.
    Furukawa T, Kubota T, Watanabe M, Kuo TH, Kase S, Saikawa Y, Tanino H, Teramoto T, Ishibiki K, Kitajima M.
    Anticancer Res; 1993 Dec 01; 13(2):287-91. PubMed ID: 8517641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
    Hihara J, Yamaguchi Y, Minami K, Noma K, Toge T.
    Anticancer Res; 1999 Dec 01; 19(2A):1077-84. PubMed ID: 10368657
    [Abstract] [Full Text] [Related]

  • 11. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T.
    Int J Oncol; 2004 Apr 01; 24(4):959-66. PubMed ID: 15010836
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y, Satoh Y, Miyahara E, Noma K, Funakoshi M, Takashima I, Sawamura A, Toge T.
    Anticancer Res; 1995 Apr 01; 15(5B):2201-6. PubMed ID: 8572625
    [Abstract] [Full Text] [Related]

  • 15. [Metastatic behavior of footpad-inoculated tumors in mice and the impact of OK-432 per os administration].
    Nakajima Y, Akimoto M, Kimura M, Iwasaki H, Matano S, Hirakawa H, Mori S.
    Gan To Kagaku Ryoho; 1987 May 01; 14(5 Pt 1):1229-33. PubMed ID: 3579323
    [Abstract] [Full Text] [Related]

  • 16. [Anti-tumor effect of intratumoral administration of dendritic cells in combination with TS-1 and OK-432].
    Okamoto M, Ahmed SU, Oshikawa T, Tano T, Sato M.
    Gan To Kagaku Ryoho; 2004 Oct 01; 31(11):1627-30. PubMed ID: 15553665
    [Abstract] [Full Text] [Related]

  • 17. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M.
    Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
    Takahashi M, Narisawa T, Masuda T, Nagasawa O, Suzuki K, Yoshioka H, Koyama H.
    Gan To Kagaku Ryoho; 1987 Jul 01; 14(7):2334-40. PubMed ID: 3111384
    [Abstract] [Full Text] [Related]

  • 20. Stable long-term induction of perforin-positive CD8+ T cells in gut by oral administration of streptococcal preparation OK-432.
    Mino N, Naomoto Y, Shirakawa Y, Matsuoka J, Nobuhisa T, Gunduz M, Noma K, Nagatsuka H, Kobayashi M, Yamatsuji T, Haisa M, Gochi A, Tanaka N.
    Int J Mol Med; 2004 Nov 01; 14(5):801-6. PubMed ID: 15492848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.